Mark Bodmer - CSO, President of R&D at Evelo Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CSO, President of R&D
Issuer Symbol
EVLO on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Bodmer since 07 Mar 2025

Holdings reported by Mark Bodmer for Evelo Biosciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25,732 $8,492 $0.3300 08 Nov 2023 Direct
Restricted Stock Units 6,625 07 Nov 2023 Direct Common Stock

Transactions reported by Mark Bodmer for Evelo Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.